Mizuho analysts raised their price target for Neumora Therapeutics, Inc. on July 20, 2025.
1 report, 1 independent
Updated Jul 20
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Mizuho analysts raised their price target for Neumora Therapeutics, Inc. on July 20, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Neumora Therapeutics, Inc.
biopharmaceutical company
Nothing else this week.
-
Mizuho Securities
Japanese investment banking company
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- Insider MonkeyMizuho Lifts PT on Neumora Therapeutics (NMRA) to $5 from $4, Keeps Outperform Rating Neumora Therapeutics, Inc. (NASDAQ:NMRA) is one of the hot penny stocks to invest in now. On July 16, Mizuho anal